ES2138729T3 - Metodos de diagnostico de la preeclampsia. - Google Patents

Metodos de diagnostico de la preeclampsia.

Info

Publication number
ES2138729T3
ES2138729T3 ES95913568T ES95913568T ES2138729T3 ES 2138729 T3 ES2138729 T3 ES 2138729T3 ES 95913568 T ES95913568 T ES 95913568T ES 95913568 T ES95913568 T ES 95913568T ES 2138729 T3 ES2138729 T3 ES 2138729T3
Authority
ES
Spain
Prior art keywords
preeclampsia
diagnostic methods
methods
csf
diagnosis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES95913568T
Other languages
English (en)
Inventor
James C Keith Jr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Genetics Institute LLC
Virginia Polytechnic Institute and State University
Original Assignee
Genetics Institute LLC
Virginia Polytechnic Institute and State University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genetics Institute LLC, Virginia Polytechnic Institute and State University filed Critical Genetics Institute LLC
Application granted granted Critical
Publication of ES2138729T3 publication Critical patent/ES2138729T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/2073—IL-11
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/193—Colony stimulating factors [CSF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6863—Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/689—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to pregnancy or the gonads
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/36—Gynecology or obstetrics
    • G01N2800/368—Pregnancy complicated by disease or abnormalities of pregnancy, e.g. preeclampsia, preterm labour

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Food Science & Technology (AREA)
  • Zoology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Reproductive Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Cardiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

SE PROPORCIONAN METODOS PARA EL DIAGNOSTICO Y TRATAMIENTO DE PACIENTES CON RIESGO INCREMENTADO DE HIPERTENSION GESTACIONAL O PREECLAMPSIA. LOS METODOS INCLUYEN LA MEDICION DE NIVELES DE MCSF DE SUERO, Y LA ADMINISTRACION DE M-CSF.
ES95913568T 1994-03-10 1995-03-10 Metodos de diagnostico de la preeclampsia. Expired - Lifetime ES2138729T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/212,446 US5543138A (en) 1994-03-10 1994-03-10 Methods of diagnosing and treating preeclampsia

Publications (1)

Publication Number Publication Date
ES2138729T3 true ES2138729T3 (es) 2000-01-16

Family

ID=22791053

Family Applications (1)

Application Number Title Priority Date Filing Date
ES95913568T Expired - Lifetime ES2138729T3 (es) 1994-03-10 1995-03-10 Metodos de diagnostico de la preeclampsia.

Country Status (12)

Country Link
US (2) US5543138A (es)
EP (1) EP0749582B1 (es)
JP (2) JP4149512B2 (es)
KR (1) KR100350259B1 (es)
AT (1) ATE181422T1 (es)
AU (1) AU682593B2 (es)
CA (1) CA2184920C (es)
DE (1) DE69510336T2 (es)
DK (1) DK0749582T3 (es)
ES (1) ES2138729T3 (es)
GR (1) GR3031250T3 (es)
WO (1) WO1995024650A2 (es)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5679339A (en) * 1995-06-27 1997-10-21 Keith; James Method of using IL-11 for treating spondyloarthropies
US6540993B1 (en) 1995-06-27 2003-04-01 Wyeth Method of treating inflammatory bowel disease using a topical formulation of IL-11
US6126933A (en) * 1995-06-27 2000-10-03 Genetics Institute Methods of treating inflammatory bowel diseases by administering IL-11
US6620590B2 (en) 1996-07-11 2003-09-16 Isis Innovation Limited Diagnosis of pre-eclampsia
AU739063B2 (en) * 1996-12-24 2001-10-04 Walter And Eliza Hall Institute Of Medical Research, The A method of treatment and prophylaxis
AUPO439396A0 (en) * 1996-12-24 1997-01-23 Walter And Eliza Hall Institute Of Medical Research, The A method of treatment and prophylaxis
GB9927125D0 (en) * 1999-11-16 2000-01-12 Univ Reading The Placental human neurokinin B precursor
US6642055B1 (en) 2000-03-31 2003-11-04 Arbogast Pharmaceuticals, Inc. Method for the prediction of preeclampsia and other diseases
US7335362B2 (en) * 2002-07-19 2008-02-26 Beth Israel Deaconess Medical Center Methods of treating pre-eclampsia or eclampsia
US7435419B2 (en) * 2002-07-19 2008-10-14 Beth Israel Deaconess Medical Center Methods of diagnosing and treating pre-eclampsia or eclampsia
CA2922031C (en) * 2002-07-19 2020-12-15 Beth Israel Deaconess Medical Center, Inc. Methods of diagnosing and treating pre-eclampsia or eclampsia
US7439071B2 (en) * 2003-02-04 2008-10-21 The Administrators Of The Tulane Educational Fund Method of employing elevation of marinobufagenin in determining the presence of preeclampsia and related apparatus
WO2005017192A2 (en) * 2003-08-14 2005-02-24 The General Hospital Corporation Screening for gestational disorders
EP1664797B1 (en) * 2003-09-23 2015-11-11 The General Hospital Corporation Screening for preeclampsia
WO2005110462A2 (en) * 2004-05-04 2005-11-24 Children's Medical Center Corporation Methods and compositions for treatment of preeclampsia
US20060024677A1 (en) * 2004-07-20 2006-02-02 Morris David W Novel therapeutic targets in cancer
DE602005024850D1 (de) * 2004-09-24 2010-12-30 Beth Israel Hospital Verfahren zur diagnose und behandlung von schwangerschaftsskomplikationen
US7740849B2 (en) * 2004-09-24 2010-06-22 Beth Israel Deaconess Medical Center Use of compounds that bind soluble endoglin and SFLT-1 for the treatment of pregnancy related hypertensive disorders
US7955805B2 (en) * 2004-12-15 2011-06-07 Beth Israel Deaconess Medical Center Nucleic acids and polypeptides useful for diagnosing complications of pregnancy
US20060212484A1 (en) * 2005-03-18 2006-09-21 Chaffin David G Jr System and method for evaluating, monitoring, diagnosing, and treating hypertension and other medical disorders
US20090286271A1 (en) * 2006-05-31 2009-11-19 Karumanchi Ananth S Methods of Diagnosing and Treating Complications of Pregnancy
DK2373148T3 (da) * 2008-12-19 2019-08-19 Pasteuria Bioscience Inc Materialer og fremgangsmåder til bekæmpelse af nematoder med Pasteuria-sporer i frøbelægninger

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5198366A (en) * 1986-03-23 1993-03-30 Technion Research & Development Foundation Ltd. Method for the detection of pregnancy disorders
US4868119A (en) * 1986-12-11 1989-09-19 Genetics Institute, Inc. Hematopoietic growth factors
US4879227A (en) * 1986-05-06 1989-11-07 Genetics Institute, Inc. Production of a recombinant human colony stimulating factor
US5079171A (en) * 1988-09-15 1992-01-07 Adeza Biomedical Corporation Determining pregnancy induced hypertension and eclampsia by immunoassay of cellular fibronectin
JPH04505804A (ja) * 1988-12-14 1992-10-08 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア 子癇前症の検出のための診断的検定
US5211947A (en) * 1988-12-16 1993-05-18 Schering Corporation Method for lowering blood cholesterol levels with granulocyte-macrophage colony stimulating factor
EP0642667B1 (en) * 1991-11-04 2001-01-10 Adeza Biomedical Corporation Screening method for identifying women at increased risk for preterm delivery

Also Published As

Publication number Publication date
CA2184920C (en) 2007-10-30
WO1995024650A2 (en) 1995-09-14
DE69510336T2 (de) 2000-02-24
US5543138A (en) 1996-08-06
JP2004029031A (ja) 2004-01-29
DK0749582T3 (da) 1999-11-22
JPH09510292A (ja) 1997-10-14
JP3741697B2 (ja) 2006-02-01
CA2184920A1 (en) 1995-09-14
GR3031250T3 (en) 1999-12-31
DE69510336D1 (de) 1999-07-22
AU2095495A (en) 1995-09-25
AU682593B2 (en) 1997-10-09
WO1995024650A3 (en) 1995-10-05
EP0749582A1 (en) 1996-12-27
KR100350259B1 (ko) 2002-10-18
EP0749582B1 (en) 1999-06-16
JP4149512B2 (ja) 2008-09-10
ATE181422T1 (de) 1999-07-15
US5580554A (en) 1996-12-03

Similar Documents

Publication Publication Date Title
ES2138729T3 (es) Metodos de diagnostico de la preeclampsia.
NO973510L (no) Diagnotiske avbildningskontrastmidler med forlenget blodretensjon
EP0671920A4 (en) AN ANTI-IDIOTYPICAL ANTIBODY AND ITS USE IN THE DIAGNOSIS AND THERAPY OF HIV-RELATED DISEASES.
DE69535349D1 (de) Implantierbare aktive medizinische Vorrichtung mit Mittel zur Unterscheidung zwischen Ruhe- bzw. Aktivzustand des Patienten
DE69510810T2 (de) Lamanin-ketten: diagnostische und therapeutische verwendung
DE68911975T2 (de) Ophthalmoskopisches Diagnoseverfahren und Gerät.
DE69628844D1 (de) Leishmania-antigene zur anwendung in der leishmaniasis therapie und diagnose
DE820303T1 (de) p277 PEPTIDANALOGE, PHARMAZEUTISCHE ZUSAMMENSTELLUNG DAVON ZUR BEHANDLUNG UND DIAGNOSE VON DIABETES
DE59608213D1 (de) Arzneimittel zur immuntherapie, enthaltend antikörper, die spezifisch das mhcii-antigen eines zu behandelnden patienten erkennen
KR950700726A (ko) 치료 또는 진단용 조성물, 그 제조방법 및 용도(composition for therapeutic or diagnostic use, process for its preparation and its use)
FI933291A (fi) Foerfarande foer paovisning av anti-rna-antikroppar
AU2579995A (en) Alpha b crystallin for use in diagnosis and therapy of auto-immune diseases in particular multiple sclerosis
BR0110512A (pt) Preparação para medir a taxa de esvaziamento gástrico
FR2608767B1 (fr) Procede pour la detection et le dosage des anticorps anti-(sporozoaires de p. falciparum) dans le sang humain et trousses de diagnostic pour mettre en oeuvre ce procede
NO963347L (no) Fremgangsmåte for identifisering av individer som lider av en cellulær abnormitet
IT8521309A0 (it) Dispositivo e procedimento per sterilizzare articoli, in particolare strumenti chirurgici, strumenti odontotecnici e simili.
WO2000073338A8 (en) Compositions and methods for the therapy, diagnosis and monitoring of breast cancer
UA33330A (uk) Спосіб діагностики ендогенної інтоксикації
UA10262A (uk) Спосіб ультразвукової діагностики стану судин головного мозку
UA34311A (uk) Спосіб оцінки клінічного стану хворого
UA23312A (uk) Спосіб діагhостики холелітіазу
AU3651595A (en) Drug for the prevention and treatment of auto-immune and viral diseases, and diagnostic agents for detecting said diseases
UA36246A (uk) Спосіб діагностики і препарування прихованих каріозних уражень апроксимальних поверхонь молярів нижче екватору
DE29621571U1 (de) Magnet zur Diagnose und Therapie am Patienten
UA31276A (uk) Спосіб діагностики хламідіозу і мікоплазмозу у хворих на ранній сифіліс

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 749582

Country of ref document: ES